The Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...

Complex Pandemic Accord negotiations have been under way since 2021, with 13 formal meetings and numerous informal sessions.

Yesterday, the US Centers for Disease Control and Prevention (CDC) issued a level 2 travel notice (practice enhanced ...

A review of 600 US patients treated for suspected sepsis found 32% most likely didn't have a bacterial infection, while ...

Workers who received Novavax reported 12.5% fewer local reactions than those who received the Pfizer vaccine. Average hours ...

Currently, there are no approved vaccines for Marburg virus disease.

Dr. Ngashi Ngongo, the Principal Advisor to the Director General of Africa CDC on Programs, represented H.E. Dr. Jean Kaseya at the official handover ceremony in Luanda.

Burundi has revised and approved its Mpox Response Plan and Marburg-Ebola Preparedness Plan, signaling a high-level commitment to strengthening outbreak response efforts in the country.A validation ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent 09.04.2025 / 15:07 CET/CEST The issuer is solely responsible ...

Africa CDC supported national responses to multiple major public health emergencies, including the mpox outbreak in 20 member states and the Marburg virus disease in Rwanda. Africa CDC declared mpox a ...